Alexion: aiming to break new ground in ultra-rare therapiesMartin Mackay, head of R&D at Alexion, talks to pharmaphorum about the company’s research pipeline for severe and Share XAlexion: aiming to break new ground in ultra-rare therapieshttps://pharmaphorum.com/articles/alexion-aiming-to-break-new-ground-in-ultra-rare-therapies/
